Aller au contenu principal
Fermer
  2. Aide
  2. Aide

Inventiva to present at the 40th Annual J.P. Morgan Healthcare Conference
information fournie par Boursorama CP 16/12/2021 à 22:00

Daix (France), Long Island City (New York), December 16, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, has been invited to present a corporate overview, followed by a Q&A session, and will engage, with Inventiva’s leadership team, in 1x1 investor meetings at the upcoming 40th Annual J.P. Morgan Annual Healthcare Conference, being held virtually on January 10-13, 2022.

Valeurs associées

INVENTIVA
3,0150 EUR Euronext Paris -3,05%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

valeur

dernier

var.
2CRSI
25,44 -4,36%
CAC 40
8 443,88 +0,70%
Pétrole Brent
73,27 +0,18%
SOITEC
110,7 +3,17%
TOTALENERGIES
68,54 -1,40%
Chargement...

Pages les plus populaires

L'offre BoursoBank